Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 275 of 2228 entries
View as:

Effect of BI 1181181 on Midazolam, Warfarin, Omeprazole and Digoxin

Phase: N/A Priority: Normal
NCT ID: NCT02345304 Org: User:
Start: 03/31/15 End: 05/31/15 Due: 05/31/16

A Study to Test How Well Different Doses of BI 3006337 Are Tolerated by People With Overweight or Obesity and With Fatty Liver Disease

Phase: N/A Priority: Normal
NCT ID: NCT05970640 Org: User:
Start: 08/14/23 End: 11/07/24 Due: 11/07/25

A Study to Test Different Imaging Techniques in Patients With Different Types of Interstitial Lung Disease

Phase: N/A Priority: Normal
NCT ID: NCT05492994 Org: User:
Start: 12/19/22 End: 03/02/27 Due: 03/02/28

4 Week Treatment With Three Oral Doses of BI 10773 in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00558571 Org: User:
Start: 01/31/08 End: - Due: -

A Study to Test How Well BI 1291583 is Tolerated by People With Cystic Fibrosis Bronchiectasis (Clairafly™)

Phase: N/A Priority: Normal
NCT ID: NCT05865886 Org: User:
Start: 04/05/24 End: 10/07/24 Due: 10/07/25

This Study Tests Different Doses of BI 1015550 in Patients With Idiopathic Pulmonary Fibrosis (IPF). The Study Tests How BI 1015550 is Taken up by the Body and How Well it is Tolerated.

Phase: N/A Priority: Normal
NCT ID: NCT03422068 Org: User:
Start: 03/16/18 End: 07/10/19 Due: 07/10/20

Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT01019694 Org: User:
Start: 11/30/09 End: - Due: -

Efficacy and Safety of Meloxicam vs. Naproxen Sodium in Patients With Acute Non Bacterial Pharyngitis or Pharyngo-tonsillitis

Phase: N/A Priority: Normal
NCT ID: NCT02183038 Org: User:
Start: 07/31/98 End: - Due: -

Micardis® in Patients With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02187705 Org: User:
Start: 05/31/99 End: - Due: -

A Study to Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus

Phase: N/A Priority: Normal
NCT ID: NCT06056024 Org: User:
Start: 12/06/23 End: 05/26/27 Due: 05/26/28

MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin

Phase: N/A Priority: Normal
NCT ID: NCT01792518 Org: User:
Start: 02/28/13 End: 12/31/15 Due: 12/31/16

BI 2536 Infusional Treatment in Patients Over 60 Years of Age With Refractory or Relapsed Acute Myeloid Leukaemia

Phase: N/A Priority: Normal
NCT ID: NCT00701766 Org: User:
Start: 10/31/06 End: - Due: -

A Study to Test How BI 456906 is Taken up in the Blood of People With and Without Kidney Problems

Phase: N/A Priority: Normal
NCT ID: NCT06352411 Org: User:
Start: 05/15/24 End: 08/29/25 Due: 08/29/26

A Study to Test the Effect of Different Doses of Avenciguat (BI 685509) on Kidney Function in People With Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT04736628 Org: User:
Start: 04/27/21 End: 09/21/23 Due: 09/21/24

A Study in Healthy People to Test Whether Erythromycin Influences the Amount of BI 1291583 in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT06917872 Org: User:
Start: 04/29/25 End: 09/01/25 Due: 09/01/26

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effects of Multiple Rising Subcutaneous Doses of BI 655064 in Healthy Volunteers and in Rheumatoid Arthritis Patients With Prior Inadequate Response to Methotrexate Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01751776 Org: User:
Start: 12/18/12 End: 04/27/15 Due: 04/27/16

Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine, Abacavir and Amprenavir in HIV-1 Infected Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Naive Adults

Phase: N/A Priority: Normal
NCT ID: NCT02182765 Org: User:
Start: 04/30/99 End: - Due: -

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01345682 Org: User:
Start: 01/05/12 End: 12/06/16 Due: 12/06/17

An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.

Phase: N/A Priority: Normal
NCT ID: NCT00528996 Org: User:
Start: 09/06/07 End: 05/05/09 Due: 05/05/10

A Study in Healthy Men to Test How Different Doses of BI 3032950 Are Tolerated

Phase: N/A Priority: Normal
NCT ID: NCT05518708 Org: User:
Start: 09/27/22 End: 09/21/23 Due: 09/21/24

IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1

Phase: N/A Priority: Normal
NCT ID: NCT01732796 Org: User:
Start: 12/31/12 End: 01/31/15 Due: 01/31/16

MEN STUDY (ESTUDIO MEN) Quality of Life in Patients With BPH and Nocturia Before and After Tamsulosin Ocas® Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00885027 Org: User:
Start: 03/31/09 End: - Due: -

LUX Lung Special Access Scheme Australia Named Patient Use (NPU)

Phase: N/A Priority: Normal
NCT ID: NCT01209650 Org: User:
Start: - End: - Due: -

Bioequivalence of a Fixed Dose Combination Tablet Containing 400 mg Ibuprofen and 60 mg Pseudoephedrine-HCl Compared to Two Film Coated Fixed Dose Combination Tablets RhinAdvil(R)(200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl) Administered in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02963701 Org: User:
Start: 12/20/16 End: 02/08/17 Due: 02/08/18

Trial Comparing Tiotropium Inhalation Capsules vs Placebo in Chronic Obstructive Pulmonary Disease (COPD).

Phase: N/A Priority: Normal
NCT ID: NCT00523991 Org: User:
Start: 04/30/07 End: - Due: -